Abstract:Brachytherapy (BT) is advantageous due to high absorbed dose conformity and possibility to deliver high dose in few fractions. It is often used for prostate and gynecological tumors as monotherapy or as a boost alongside external beam radiotherapy (EBRT). However, a number of things can compromise treatment delivery, starting from incorrect source data in a treatment planning system to malfunctioning of a treatment delivery unit. The established quality assurance (QA) covers individual aspects, such as softwar… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.